KR910009929A - 진핵세포에서 신경성장인자의 발현을 위한 유전자 구조의 제조방법 - Google Patents

진핵세포에서 신경성장인자의 발현을 위한 유전자 구조의 제조방법 Download PDF

Info

Publication number
KR910009929A
KR910009929A KR1019900018690A KR900018690A KR910009929A KR 910009929 A KR910009929 A KR 910009929A KR 1019900018690 A KR1019900018690 A KR 1019900018690A KR 900018690 A KR900018690 A KR 900018690A KR 910009929 A KR910009929 A KR 910009929A
Authority
KR
South Korea
Prior art keywords
ngf
human
fragment
make
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019900018690A
Other languages
English (en)
Korean (ko)
Inventor
델라발레 프란세스코
칼레가로 란프란코
네그로 알레산드로
Original Assignee
프란세스코 델라 발레
피디아 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프란세스코 델라 발레, 피디아 에스.피.에이. filed Critical 프란세스코 델라 발레
Publication of KR910009929A publication Critical patent/KR910009929A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019900018690A 1989-11-16 1990-11-16 진핵세포에서 신경성장인자의 발현을 위한 유전자 구조의 제조방법 Ceased KR910009929A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT04856489A IT1238348B (it) 1989-11-16 1989-11-16 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
IT48564A/89 1989-12-16

Publications (1)

Publication Number Publication Date
KR910009929A true KR910009929A (ko) 1991-06-28

Family

ID=11267348

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900018690A Ceased KR910009929A (ko) 1989-11-16 1990-11-16 진핵세포에서 신경성장인자의 발현을 위한 유전자 구조의 제조방법

Country Status (22)

Country Link
US (1) US5457034A (https=)
EP (1) EP0432510B1 (https=)
JP (2) JP3121611B2 (https=)
KR (1) KR910009929A (https=)
CN (1) CN1051934A (https=)
AR (1) AR246983A1 (https=)
AT (1) ATE214735T1 (https=)
CA (1) CA2030108C (https=)
DE (1) DE69033937T2 (https=)
ES (1) ES2173856T3 (https=)
FI (1) FI905691L (https=)
HU (1) HUT61047A (https=)
IE (1) IE904120A1 (https=)
IL (1) IL96347A (https=)
IT (1) IT1238348B (https=)
NZ (1) NZ236058A (https=)
PE (1) PE28191A1 (https=)
PL (1) PL287811A1 (https=)
PT (1) PT95911B (https=)
TW (1) TW205069B (https=)
YU (1) YU217890A (https=)
ZA (1) ZA909122B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
DE60040678D1 (en) 1999-09-29 2008-12-11 Gen Hospital Corp Parathyroid hormon (pth) polypeptidderivate
EP1305040B1 (en) * 2000-07-28 2009-09-09 Christopher J. Murphy Transplant media
CA2454275C (en) * 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US7795220B2 (en) 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CN101260398B (zh) * 2007-03-07 2013-06-05 舒泰神（北京）生物制药股份有限公司 神经生长因子基因定位改造动物及其制备方法和应用
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
CN101927012B (zh) * 2009-06-26 2013-08-14 丽珠医药集团股份有限公司 神经生长因子的病毒灭活方法
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN102816766A (zh) * 2012-05-04 2012-12-12 沈阳医学院 蛇毒神经生长因子活性多肽的筛选方法
JP2024527197A (ja) * 2021-07-30 2024-07-23 チェンドゥ ユノヴェル バイオファーマ カンパニー リミテッド． 組換えｃｈｏ細胞、その構築方法、並びにそれを用いた検出システム及び方法
CN115894705A (zh) * 2021-09-30 2023-04-04 三生国健药业（上海）股份有限公司 一种β-NGF融合蛋白、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4796580A (en) * 1987-09-11 1989-01-10 Allied-Signal Inc. Idle control valve for use with a throttle assembly of an internal combustion engine
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
YU217890A (sh) 1993-05-28
PT95911A (pt) 1991-09-13
JPH03224490A (ja) 1991-10-03
ES2173856T3 (es) 2002-11-01
IL96347A0 (en) 1991-08-16
FI905691A7 (fi) 1991-05-17
IL96347A (en) 1997-11-20
IT8948564A1 (it) 1991-05-16
CA2030108C (en) 1998-04-28
JP3121611B2 (ja) 2001-01-09
EP0432510B1 (en) 2002-03-20
TW205069B (https=) 1993-05-01
DE69033937D1 (de) 2002-04-25
ZA909122B (en) 1991-09-25
HU907174D0 (en) 1991-05-28
AU645998B2 (en) 1994-02-03
US5457034A (en) 1995-10-10
IT1238348B (it) 1993-07-13
EP0432510A1 (en) 1991-06-19
FI905691A0 (fi) 1990-11-16
IT8948564A0 (it) 1989-11-16
PL287811A1 (en) 1991-12-02
NZ236058A (en) 1993-04-28
ATE214735T1 (de) 2002-04-15
AR246983A1 (es) 1994-10-31
JP2001000194A (ja) 2001-01-09
HUT61047A (en) 1992-11-30
CA2030108A1 (en) 1991-05-17
FI905691L (fi) 1991-05-17
AU6655890A (en) 1991-05-23
PE28191A1 (es) 1991-10-28
DE69033937T2 (de) 2002-11-14
PT95911B (pt) 1998-01-30
IE904120A1 (en) 1991-05-22
CN1051934A (zh) 1991-06-05

Similar Documents

Publication Publication Date Title
KR910009929A (ko) 진핵세포에서 신경성장인자의 발현을 위한 유전자 구조의 제조방법
Kim et al. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells
Chu et al. Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta
Reisner Similarity between the vaccinia virus 19K early protein and epidermal growth factor
US20050256035A1 (en) Ctp-extended erythropoietin
DE3586750T2 (de) Rekombinante fusionsproteine.
US4888286A (en) Production of gene and protein analogs through synthetic gene design using double stranded synthetic oligonucleotides
DE3880468D1 (de) Rekombinante dns-expressionsvektoren.
KR880700858A (ko) 재조합된 인간의 내피성 세포의 생장인자
GEP19970775B (en) Method for the production of human erythropoietin
KR970703429A (ko) 동종 재조합에 영향을 주는 dna 구성물 및 이것의 사용 방법(dna construct for effecting homologous recombination and uses thereof)
LU90591I2 (fr) Enbrel-etanercept
IE57013B1 (en) Biosynthetically produced human nerve growth factor,process for producing it,compositions containing it,dna sequence encoding it,vectors containing the sequence and host cells transformed thereby
EP0204401A1 (en) Method of improving the yield of polypeptides produced in a host cell by stabilizing mRNA
NO327165B1 (no) Rekombinant mistellectin, fremgangsmate for fremstilling derav, nukleinsyre som koder for dette, vektor, vertscelle samt legemiddel og diagnostisk blanding.
KR870001310A (ko) 인체 i형 인터페론 펩타이드의 제조방법
Manos Expression and processing of a recombinant human macrophage colony-stimulating factor in mouse cells
EP0542679A1 (en) Novel hybrid transforming growth factors
Cawley et al. Nucleotide sequence of cDNA encoding the catalytic subunit of phosphorylase kinase from rat soleus muscle
EP0215110A1 (en) PRODUCTION OF HUMAN SOMATOMEDIN C.
Han et al. A novel recombinant dual human SCF expressed in and purified from silkworm, Bombyx mori, possesses higher bioactivity than recombinant monomeric human SCF
Kelley et al. Synthesis of fusion and mature murine alpha interferons in Escherichia coli
Johnson Characterization of cDNA clones encoding the human homologue of Saccharomyces cerevisiae ribosomal protein L30
US5654177A (en) Production of human somatomedin C
DE69121227D1 (de) Polypeptid

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19901116

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19951115

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19901116

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980720

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19980930

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19980720

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 19990111

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 19980930

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19991030

Appeal identifier: 1999101000147

Request date: 19990111

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19990111

Effective date: 19991030

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 19991105

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 19990111

Decision date: 19991030

Appeal identifier: 1999101000147